These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29928272)

  • 1. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
    Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
    Front Immunol; 2018; 9():1113. PubMed ID: 29928272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis.
    Swart A; Burlingame RW; Gürtler I; Mahler M
    Clin Chim Acta; 2012 Dec; 414():266-72. PubMed ID: 23022338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies.
    Webb T; Lakos G; Swart A; Gürtler I; Favalli EG; Schioppo T; Mahler M
    Clin Chim Acta; 2014 Nov; 437():161-7. PubMed ID: 25086283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
    Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
    Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
    J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.
    dos Anjos LM; Pereira IA; d 'Orsi E; Seaman AP; Burlingame RW; Morato EF
    Clin Rheumatol; 2009 Feb; 28(2):153-8. PubMed ID: 18795390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of second- and third-generation immunoassays for detection of anti-cyclic citrullinated peptide antibodies.
    Ji M; Hur M; Moon HW; Park M; Yun YM; Lee SH
    Scand J Clin Lab Invest; 2018 Oct; 78(6):477-482. PubMed ID: 30073867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.
    Elshafie AI; Elbagir S; Aledrissy MIE; Elagib EM; Nur MAM; Rönnelid J
    Clin Rheumatol; 2019 Jun; 38(6):1545-1553. PubMed ID: 30656490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis.
    Sieghart D; Konrad C; Swiniarski S; Haslacher H; Aletaha D; Steiner G
    Front Immunol; 2022; 13():1096866. PubMed ID: 36685579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
    Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
    Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease.
    Demoruelle MK; Parish MC; Derber LA; Kolfenbach JR; Hughes-Austin JM; Weisman MH; Gilliland W; Edison JD; Buckner JH; Mikuls TR; O'Dell JR; Keating RM; Gregersen PK; Norris JM; Holers VM; Deane KD
    Arthritis Rheum; 2013 Sep; 65(9):2243-52. PubMed ID: 23686569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population.
    Szekanecz Z; Szabó Z; Zeher M; Soós L; Dankó K; Horváth I; Lakos G
    Immunol Res; 2013 Jul; 56(2-3):439-43. PubMed ID: 23592053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.
    Santiago M; Baron M; Miyachi K; Fritzler MJ; Abu-Hakima M; Leclercq S; Bell M; Hudson M; Mathieu JP; Taillefer S; Jones N; Docherty P; Khraishi M; Markland J; Pope J; Robinson D; Smith D; Sutton E
    Clin Rheumatol; 2008 Jan; 27(1):77-83. PubMed ID: 17570008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
    Bertin D; Dubucquoi S; Lakomy D; Deleplancque AS; Desplat-Jégo S
    Immunol Res; 2016 Apr; 64(2):455-60. PubMed ID: 26350265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis?
    Singh U; Vishwanath A; Verma PK; Singh NK; Shukla RC; Singh S; Singh S; Sonkar GK
    Rheumatol Int; 2010 Jun; 30(8):1115-9. PubMed ID: 20058015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.